Parkinson’s Disease Epidemiology Forecast to 2030

Parkinson’s Disease Epidemiology Forecast to 2030

Parkinson’s Disease Epidemiology
DelveInsight’s “Parkinson’s Disease Epidemiology Forecast to 2030” report delivers an in-depth understanding of the disease, historical and forecasted Parkinson’s Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

DelveInsight launched a new report on Parkinson’s Disease Epidemiology Forecast to 2030

Some of the key facts of the report:-

  1. The total diagnosed Parkinson’s Disease prevalent population in the 7MM is expected to rise to 3,284,084 in 2030, during the study period [2017–2030]. 
  2. The highest diagnosed Parkinson’s Disease prevalent population was in the United States.
  3. Males are more prominent for developing Parkinson’s Disease in comparison to female.
  4. Primary Parkinsonism or Idiopathic Parkinson’s cases are prominent in comparison to Secondary or atypical parkinsonism.

 

Request for sample pages:- https://www.delveinsight.com/sample-request/parkinsons-disease-epidemiology-forecast

 

 

Scope of the Report

  • The Parkinson’s Disease report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Parkinson’s Disease Epidemiology Report and Model provide an overview of the risk factors and global trends of Parkinson’s Disease in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Parkinson’s Disease in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Parkinson’s Disease.
  • The report provides the segmentation of the Parkinson’s Disease epidemiology

 

 

Reasons to buy

  • The Parkinson’s Disease Epidemiology report will allow the user to –
  • Develop business strategies by understanding the trends shaping and driving the global Parkinson’s Disease market
  • Quantify patient populations in the global Parkinson’s Disease market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Parkinson’s Disease therapeutics in each of the markets covered
  • Understand the magnitude of Parkinson’s Disease population by its epidemiology
  • The Parkinson’s Disease Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

 

 

Request for sample pages:- https://www.delveinsight.com/sample-request/parkinsons-disease-epidemiology-forecast

 

 

 Table of contents

1. Key Insights 

2. Executive Summary of Parkinson’s Disease

3. Parkinson’s Disease Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Parkinson’s Disease Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1. Parkinson’s Disease Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Parkinson’s Disease Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1. Parkinson’s Disease Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Parkinson’s Disease Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Parkinson’s Disease Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Parkinson’s Disease Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1. Parkinson’s Disease Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Parkinson’s Disease Treatment and Management

6.2. Parkinson’s Disease Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

 

 

Related reports :-

Parkinson’s Disease- Market Insight, Epidemiology and Market Forecast -2030

DelveInsight’ s Parkinson’s Disease – Market Insights, Epidemiology and Market Forecast – 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

 

Parkinson’s Disease – Pipeline Insights, 2020

Parkinson’s Disease Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Parkinson’s Disease market.

 

Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/